Blog

Research evidence from major clinical trials reveals significant differences between semaglutide and tirzepatide in their mechanisms of action and effectiveness. Both GLP-1-based compounds show promising results for weight management and metabolic health, with distinct advantages and considerations.

Mounjaro and Wegovy represent the latest breakthrough in weight loss injections, with both showing remarkable results in clinical trials. This comprehensive comparison examines their effectiveness, availability on the NHS, and which might be the better choice for your weight loss journey.

Wegovy and Ozempic are both brand names for semaglutide by Novo Nordisk, but they serve different purposes and come in different doses. Understanding their distinctions is crucial for UK patients considering either medication.

Retatrutide isn't yet commercially available in the UK, but research institutions can access it through licensed suppliers. No approved NHS or private prescriptions exist currently.

Tirzepatide (Mounjaro) is a dual GLP-1/GIP receptor agonist originally developed for type 2 diabetes that has shown remarkable efficacy for weight management, offering superior results compared to semaglutide.

Semaglutide is a GLP-1 receptor agonist peptide used for type 2 diabetes and weight management. Available in the UK as Ozempic and Wegovy through NHS or private prescription.

Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors for weight loss. Currently in Phase 3 trials, it shows superior results to semaglutide and tirzepatide.

Melanotan is a synthetic peptide that mimics melanocyte-stimulating hormone (MSH), developed to stimulate melanin production and create a tanning effect.

BPC-157 is a synthetic peptide derived from a protective protein found in human gastric juice. Research suggests it may promote healing of muscles, tendons, and gut tissue.

Peptides are chains of amino acids that act as signalling molecules in the body. This comprehensive UK guide explains peptide types, mechanisms, legality, and therapeutic applications in 2026.

Peptide side effects range from mild injection site reactions to serious metabolic changes. Understanding risks helps you make informed decisions about peptide therapy.

Mounjaro and Ozempic are both effective for weight loss, but Mounjaro (tirzepatide) shows superior results in clinical trials with greater weight reduction and better glucose control.

Learn proper BPC-157 injection technique with our comprehensive UK guide. Covers subcutaneous and intramuscular methods, dosage protocols, and safety considerations.

Semaglutide works by mimicking GLP-1, a hormone that regulates blood sugar and appetite. It slows gastric emptying, enhances insulin sensitivity, and signals satiety.

Peptides show promising research results for weight management, tissue healing, and longevity, with compounds like semaglutide proving highly effective. However, evidence varies significantly by peptide type and application.

Peptides and steroids are entirely different compounds. Peptides are chains of amino acids that act as signalling molecules, whilst steroids are lipid-based hormones with distinct molecular structures and mechanisms of action.

**Peptides carry both therapeutic promise and safety risks**. While research demonstrates potential benefits, side effects range from mild injection-site reactions to serious complications. UK regulatory status varies by peptide type.

Peptides exist in a legal grey area in the UK. While not banned outright, most research peptides cannot be legally sold for human consumption under MHRA regulations.

Key factors to consider when selecting a peptide supplier, including lab testing and reviews.

Everything you need to know about BPC-157, from mechanisms of action to dosing protocols.

A comprehensive overview of the current regulatory landscape for peptides in the United Kingdom.